Exagen Analyst Price Targets - Benzinga

Exagen Inc

XGNNASDAQ

Trade with Public

Trade with Public

$7.58

0.040.53%

At close: Sep 4, 5:00 PM EST

$7.73

0.151.98%

After Hours: Sep 4, 4:30 PM EST

Overview News Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Options Stock Report

Exagen Analyst Price Targets

Wall Street analyst price targets and consensus rating for Exagen (XGN).

Price Target Range — 9 Quarters

Analyst Consensus — 8 Analysts

8Buy

Consensus RatingBuy# Analysts8Avg. Consensus PT$9Upside to Avg. PT+19.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 5, 2026	TD Cowen	Dan Brennan	PT Raise	Buy	$8→$10
Aug 5, 2026	B. Riley Securities	Anderson Schock	PT Raise	Buy	$8→$12
Aug 5, 2026	BTIG	Mark Massaro	PT Raise	Buy	$8→$9
Jun 25, 2026	Roth Capital	Max Masucci	Initiate	Buy	$8
May 12, 2026	BTIG	Mark Massaro	PT Cut	Buy	$9→$8
Apr 20, 2026	Canaccord Genuity	Kyle Mikson	PT Cut	Buy	$10→$8
Mar 11, 2026	Canaccord Genuity	Kyle Mikson	PT Cut	Buy	$15→$10
Mar 11, 2026	Craig-Hallum	John Wilkin	PT Cut	Buy	$12→$10
Mar 11, 2026	Keybanc	Paul Knight	PT Cut	Overweight	$15→$10
Mar 10, 2026	BTIG	Mark Massaro	PT Cut	Buy	$10→$9
Feb 24, 2026	TD Cowen	Dan Brennan	PT Cut	Buy	$13→$10
Feb 17, 2026	BTIG	Mark Massaro	PT Cut	Buy	$15→$10
Jan 30, 2026	B. Riley Securities	Anderson Schock	PT Cut	Buy	$18→$8
Nov 10, 2025	BTIG	Mark Massaro	PT Raise	Buy	$13→$15
Nov 5, 2025	B. Riley Securities	Anderson Schock	PT Raise	Buy	$15→$18
Oct 27, 2025	Canaccord Genuity	Kyle Mikson	PT Raise	Buy	$11→$15
Oct 22, 2025	BTIG	Mark Massaro	PT Raise	Buy	$11→$13
Oct 14, 2025	Keybanc	Paul Knight	PT Raise	Overweight	$12→$15
Sep 11, 2025	B. Riley Securities	Anderson Schock	Initiate	Buy	$15
Jul 30, 2025	Canaccord Genuity	Kyle Mikson	PT Raise	Buy	$8→$11

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
TD Cowen Maintains Buy on Exagen, Raises Price Target to $10

TD Cowen analyst Dan Brennan maintains Exagen (NASDAQ:XGN) with a Buy and raises the price target from $8 to $10.

Benzinga Newsdesk

PRO
B. Riley Securities Reiterates Buy on Exagen, Raises Price Target to $12

B. Riley Securities analyst Anderson Schock reiterates Exagen (NASDAQ:XGN) with a Buy and raises the price target from $8 to $12.

Benzinga Newsdesk

PRO
BTIG Maintains Buy on Exagen, Raises Price Target to $9

BTIG analyst Mark Massaro maintains Exagen (NASDAQ:XGN) with a Buy and raises the price target from $8 to $9.

Benzinga Newsdesk

PRO
Roth Capital Initiates Coverage On Exagen with Buy Rating, Announces Price Target of $8

Roth Capital analyst Max Masucci initiates coverage on Exagen (NASDAQ:XGN) with a Buy rating and announces Price Target of $8.

Benzinga Newsdesk

PRO
Watching Exagen; Shares See Volume To The Upside, Hearing Zacks Under $10 Newsletter Picks Stock

Benzinga Newsdesk

PRO
BTIG Maintains Buy on Exagen, Lowers Price Target to $8

BTIG analyst Mark Massaro maintains Exagen (NASDAQ:XGN) with a Buy and lowers the price target from $9 to $8.

Benzinga Newsdesk